New River Receives Approval Letter
New River Pharmaceuticals Inc. (NRPH) received an approval letter from the FDA for the attention deficit and hyperactivity treatment it developed with Shire Plc. Shares of New River leaped $16.11 to close at $42.324.
0 Comments:
Post a Comment
<< Home